First human test for new prostate drug completed
NCT ID NCT06110923
Summary
This was a first-in-human study to see how a new drug called CKD-846 moves through the body and how safe it is. It involved 31 healthy male volunteers. The goal was to gather basic safety and dosing information to see if the drug should be studied further in men with enlarged prostate (BPH).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.